Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.

Where this comes from

• Record sourced from PubMed, PMID 38295059.
• Also identified by DOI 10.1371/journal.pone.0298250 and PMC identifier 10830013.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.